Editorial: Cytochromes P450, their modulators and metabolites in cardiovascular function and disease
保存先:
主要な著者: | , , , , |
---|---|
フォーマット: | 図書 |
出版事項: |
Frontiers Media S.A.,
2024-12-01T00:00:00Z.
|
主題: | |
オンライン・アクセス: | Connect to this object online. |
タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|
MARC
LEADER | 00000 am a22000003u 4500 | ||
---|---|---|---|
001 | doaj_d23b5f7d8eae41b2a0c16ece85e6e7ac | ||
042 | |a dc | ||
100 | 1 | 0 | |a Adeniyi M. Adebesin |e author |
700 | 1 | 0 | |a Richard Joseph Roman |e author |
700 | 1 | 0 | |a William B. Campbell |e author |
700 | 1 | 0 | |a John M. Seubert |e author |
700 | 1 | 0 | |a Rheem A. Totah |e author |
245 | 0 | 0 | |a Editorial: Cytochromes P450, their modulators and metabolites in cardiovascular function and disease |
260 | |b Frontiers Media S.A., |c 2024-12-01T00:00:00Z. | ||
500 | |a 1663-9812 | ||
500 | |a 10.3389/fphar.2024.1531166 | ||
546 | |a EN | ||
690 | |a cardiovascular diseases (CVD) | ||
690 | |a cardiac hypertrophy | ||
690 | |a epoxyeicosatrienoic acid (EETs) | ||
690 | |a hydroxyeicosatetraenoic acid (HETE) | ||
690 | |a antihypertensive active components | ||
690 | |a cytochromes P450 | ||
690 | |a Therapeutics. Pharmacology | ||
690 | |a RM1-950 | ||
655 | 7 | |a article |2 local | |
786 | 0 | |n Frontiers in Pharmacology, Vol 15 (2024) | |
787 | 0 | |n https://www.frontiersin.org/articles/10.3389/fphar.2024.1531166/full | |
787 | 0 | |n https://doaj.org/toc/1663-9812 | |
856 | 4 | 1 | |u https://doaj.org/article/d23b5f7d8eae41b2a0c16ece85e6e7ac |z Connect to this object online. |